Health ❯ Healthcare ❯ Adverse Reactions

Drug Side Effects

Lurbinectedin/Atezolizumab Regimen Cytokine Release Syndrome Patient Safety Injection Site Reactions Immunocompromised Patients Fatal Adverse Reactions Diarrhea Management

FDA Approves Rusfertide (Mimrylo) for Polycythemia Vera

A once-weekly hepcidin-mimetic reducing phlebotomy need with safety concerns including anemia and thrombotic events.

FDA Approves Zanidatamab Regimens for First‑Line HER2‑Positive Gastroesophageal Cancer

FDA Grants Accelerated Approval to Sanofi’s Tzield for Children With Stage 3 Type 1 Diabetes

FDA Approves First Glucocorticoid Receptor Blocker for Platinum-Resistant Ovarian Cancer

EU Medicines Panel Backs Teizeild to Delay Type 1 Diabetes Onset

FDA Approves Lurbinectedin Plus Atezolizumab for First-Line Maintenance in Extensive-Stage SCLC